- Home
- CTMX vs NBH Comparison
CTMX vs NBH Comparison
Compare CTMX & NBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- NBH
- Stock Information
- Founded
- CTMX 2008
- NBH 2002
- Country
- CTMX United States
- NBH United States
- Employees
- CTMX N/A
- NBH N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- NBH Finance/Investors Services
- Sector
- CTMX Health Care
- NBH Finance
- Exchange
- CTMX Nasdaq
- NBH Nasdaq
- Market Cap
- CTMX 349.6M
- NBH 292.3M
- IPO Year
- CTMX 2015
- NBH N/A
- Fundamental
- Price
- CTMX $1.93
- NBH $10.48
- Analyst Decision
- CTMX Strong Buy
- NBH
- Analyst Count
- CTMX 4
- NBH 0
- Target Price
- CTMX $5.13
- NBH N/A
- AVG Volume (30 Days)
- CTMX 2.4M
- NBH 85.9K
- Earning Date
- CTMX 11-06-2025
- NBH 01-01-0001
- Dividend Yield
- CTMX N/A
- NBH 4.34%
- EPS Growth
- CTMX 263.20
- NBH N/A
- EPS
- CTMX 0.49
- NBH 0.12
- Revenue
- CTMX $141,100,000.00
- NBH N/A
- Revenue This Year
- CTMX N/A
- NBH N/A
- Revenue Next Year
- CTMX N/A
- NBH N/A
- P/E Ratio
- CTMX $3.98
- NBH $87.04
- Revenue Growth
- CTMX 18.01
- NBH N/A
- 52 Week Low
- CTMX $0.40
- NBH $8.75
- 52 Week High
- CTMX $3.10
- NBH $11.01
- Technical
- Relative Strength Index (RSI)
- CTMX 41.17
- NBH 81.89
- Support Level
- CTMX $1.90
- NBH $9.77
- Resistance Level
- CTMX $2.16
- NBH $9.95
- Average True Range (ATR)
- CTMX 0.13
- NBH 0.09
- MACD
- CTMX -0.01
- NBH 0.05
- Stochastic Oscillator
- CTMX 7.50
- NBH 97.93
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About NBH Neuberger Berman Municipal Fund Inc.
Neuberger Berman Municipal Fund Inc is a closed-end management investment company that invests mainly in municipal securities. The company aims to provide common stockholders a high level of current income exempt from Federal income tax.